National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Biodefense and Related Programs
 Biodefense
  About
  For Researchers
   Introduction
   Resources
   Funding
    FY2003 Awards
    FY2004 Awards
    FY2005 Awards
    FY2006 Awards
    FY2007 Awards
   Meetings
   Category A-C Pathogens
  Public and Media
 Radiation Countermeasures
 Chemical Countermeasures



Biodefense

Development of Therapeutic Agents for Selected Bacterial Diseases—FY2007 Awards

Institution Title
Elusys Development of Anthim a Monoclonal Antibody for the Treatment of Inhalational Anthrax
Emergent Development of Human Anthrax Immune Globulin
Nanotherapeutics Inhaled Gentamicin Dry-Powder Formulation for Postexposure Prophylaxis and Treatment of Aerosolized Pneumonic Plague and Tularemia
Pharmathene Development of Valortim a Human Monoclonal Antibody for the Treatment of Inhalational Anthrax